Antiangiogenic behaviours of heparin derivatives may effect survival in lung cancer

Thrombosis Research

Volumn 132, Issue 3, 2013, Pages

  Erdis, Eda ^a  

^a Hatay Antakya State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; HEPARIN DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN; TISSUE FACTOR PATHWAY INHIBITOR; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; DRUG EFFECT; LETTER; LUNG CANCER; METASTASIS; PRIORITY JOURNAL; THROMBOSIS PREVENTION; TREATMENT OUTCOME; TUMOR VASCULARIZATION;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION;

EID: 84883765295     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.07.016     Document Type: Letter

References (6)

1. S. Noble Low-molecular-weight heparin and survival in lung cancer Thromb Res 129 1 2012 114 118
2. N. Katrancioglu, O. Karahan, A.T. Kilic, A. Altun, O. Katrancioglu, and Z.A. Polat Comparison of the antiangiogenic effects of heparin sodium, enoxaparin sodium, and tinzaparin sodium by using chorioallantoic membrane assay Blood Coagul Fibrinolysis 23 3 2012 218 221
3. W. Sun Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy J Hematol Oncol 5 2012 63
4. S.A. Mousa Anticoagulants in thrombosis and cancer: the missing link Semin Thromb Hemost 28 2002 45 52
5. H. Takahashi, S. Ebihara, T. Okazaki, M. Asada, H. Sasaki, and M. Yamaya A comparison of the effects of unfractionated heparin, dalteparin and danaparoid on vascular endothelial growth factor-induced tumour angiogenesis and heparanase activity Br J Pharmacol 146 2005 333 343
6. O.T. Dogan, Z.A. Polat, O. Karahan, K. Epozturk, A. Altun, and I. Akkurt Antiangiogenic activities of bemiparin sodium, enoxaparin sodium, nadroparin calcium and tinzaparin sodium Thromb Res 128 4 2011 29 32